Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates. [electronic resource]
Producer: 20090429Description: 1564-71 p. digitalISSN:- 1527-7755
- Aged
- Antibodies, Monoclonal -- pharmacokinetics
- Antibodies, Monoclonal, Humanized
- Bone Density Conservation Agents -- therapeutic use
- Bone Neoplasms -- complications
- Bone Resorption -- chemically induced
- Breast Neoplasms -- pathology
- Collagen Type I -- urine
- Denosumab
- Diphosphonates -- administration & dosage
- Female
- Humans
- Male
- Middle Aged
- Multiple Myeloma -- pathology
- Peptides -- urine
- Prostatic Neoplasms -- pathology
- RANK Ligand -- antagonists & inhibitors
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.